Myeloid Cell-Derived Arginase in Cancer Immune Response

Tomasz M. Grzywa(Medical University of Warsaw), Jakub Gołąb(Medical University of Warsaw)

Frontiers in Immunology

May 15, 2020

10.3389/fimmu.2020.00938

Cited by 411

Related Papers

Small extracellular vesicles containing arginase-1 suppress T-cell responses and promote tumor growth in ovarian carcinoma

|Nature Communications|2019|309

Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice

|BMC Cancer|2008|74

Potent but transient immunosuppression of T-cells is a general feature of CD71+ erythroid cells

|Communications Biology|2021|39

Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways

|Endocrine|2019|33

Potentiated antitumor effects of the combination treatment with statins and pamidronate in vitro and in vivo

|International Journal of Oncology|2007|31